Vaiibhav Patel, MD
Advanced Heart Failure and Transplant Cardiology · Columbus, OHNPI 1659710812
Payments from drug & device makers
What this record shows
This record is dominated by grants: $8,750 of the $10,385 with a category attached, or 84.3%. Medtronic accounts for 85.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $8,847 and has fallen 83.9% since, to $1,425 in 2024.
Across 22 payments — averaging $472.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Abbott$1K
- Abiomed$185
- Alnylam Pharmaceuticals Inc.$38
- Edwards Lifesciences$16
- Nuwellis, Inc.$5
Across 15 payments — averaging $3207.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nuwellis, Inc.$48K
What the payments were for
- Grants$8,75084%
- Travel & lodging$7537%
- Food & beverage$8828%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $8,847 |
| Abbott | 13 | $1,294 |
| Abiomed | 1 | $185 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Edwards Lifesciences | 1 | $16 |
| Nuwellis, Inc. | 2 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,385 in reported general payments places this provider in the 65th percentile of 62 advanced heart failure and transplant cardiology providers in Ohio.
See all advanced heart failure and transplant cardiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 182 | $186,921 |
| FarxigaDapagliflozin Propanediol | 116 | $113,847 |
| EliquisApixaban | 89 | $91,074 |
| JardianceEmpagliflozin | 16 | $22,322 |
| XareltoRivaroxaban | 20 | $21,401 |
| Tacrolimus | 61 | $6,234 |
| Mycophenolate Mofetil | 42 | $3,914 |
| Metoprolol Succinate | 178 | $2,585 |
| Ezetimibe | 28 | $2,325 |
| Torsemide | 60 | $2,122 |
| Rosuvastatin Calcium | 160 | $1,465 |
| Atorvastatin Calcium | 169 | $1,432 |
| Potassium Chloride | 38 | $1,110 |
| Mycophenolic AcidMycophenolate Sodium | 11 | $1,099 |
| Spironolactone | 159 | $1,079 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Columbus
- William AbrahamColumbus$802K
- Rami KahwashColumbus$379K
- Beth ForemanColumbus$28K
- Ray HershbergerColumbus$6K
- Anupam BasurayColumbus$6K
- Ajay VallakatiColumbus$4K
- Katherine DoddColumbus$4K
- Lindsay CastleColumbus$3K
- Rodolfo Denadai BenattiColumbus$2K
- Yaquta KakaColumbus$859
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.